JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 28, 2004; DOI: 10.1124/jpet.104.068908


0022-3565/04/3112-728-735$20.00
JPET 311:728-735, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow All Versions of this Article:
jpet.104.068908v1
jpet.104.068908v2
311/2/728    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, E. T.
Right arrow Articles by Strobel, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, E. T.
Right arrow Articles by Strobel, H. W.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Estrogen Regulation of the Cytochrome P450 3A Subfamily in Humans

Eric T. Williams, Malgorzata Leyk, Steven A. Wrighton, Peter J. A. Davies, David S. Loose, Gregory L. Shipley, and Henry W. Strobel

Departments of Biochemistry and Molecular Biology (E.T.W., H.W.S.) and Integrative Biology and Pharmacology (P.J.A.D., D.S.L., G.L.S.), Medical School, University of Texas Health Science Center at Houston, Houston, Texas; Department of Statistics, Texas A&M University, College Station, Texas (M.L.); and Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (S.A.W.)

This study examines the possible role of estrogen in regulating the expression of the human CYP3A subfamily: CYP3A4, CYP3A5, CYP3A7, and CYP3A43. To accomplish this goal, mRNA was quantified from human livers and endometrial samples, and total CYP3A protein levels were evaluated by Western immunoblot analysis of the liver samples. The human endometrial samples were from premenopausal and postmenopausal women. The premenopausal endometrium was either in the proliferative or secretory phase, whereas for the postmenopausal endometrium samples, the women had been treated with either a placebo or estropipate, an estrogen substitute. After analyses, CYP3A4 mRNA was shown to have lower hepatic expression in females than in males. In the endometrium, CYP3A4 and CYP3A43 are down-regulated by estrogen, whereas CYP3A5 is expressed at higher levels during the secretory phase. CYP3A7 was not detected in the endometrium. In addition, the CYP3A subfamily showed increased mRNA expression in the liver as age increased. The expression levels of total CYP3A protein and total CYP3A mRNA showed good correlation. Despite apparent regulation of CYP3A4 mRNA expression by estrogen, the effects of estrogen may be overshadowed by additional regulators of gene expression.


Received April 27, 2004; accepted July 21, 2004.

Address correspondence to: Henry W. Strobel, 6431 Fannin, MSB 6.200, Houston, TX 77030. E-mail: henry.w.strobel{at}uth.tmc.edu




This article has been cited by other articles:


Home page
Hum ReprodHome page
P. Hanifi-Moghaddam, B. Boers-Sijmons, A. H.A. Klaassens, F. H. van Wijk, W. F. Van Ijcken, P. Van der Spek, H. A.M. Verheul, H. J. Kloosterboer, C. W. Burger, and L. J. Blok
Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vagina
Hum. Reprod., February 1, 2008; 23(2): 298 - 305.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.